Equitable Access to Research Is Intrinsic to Health Equity 

Equity in research plays a vital role in equity in health and health care, starting with clinical trials and carrying through post-marketing access to new vaccines and treatments. Read this blog post for a deeper dive into where the industry stands with equitable access and how it contributes to the success of a trial.

Continue ReadingEquitable Access to Research Is Intrinsic to Health Equity 

Increasing Regulatory Harmonization in Africa is Streamlining Marketing Authorization of Your Products

Dissonance in regulatory processes and timelines between countries in Africa has been cited as a major deterrent to pursuing research in the area, but times are changing. Initiatives are successfully increasing regulatory harmonization and streamlining marketing authorization across the continent.

Continue ReadingIncreasing Regulatory Harmonization in Africa is Streamlining Marketing Authorization of Your Products

High-Quality Data and Growing Capacity Make Sub-Saharan Africa a Research Destination

With experienced researchers and sites, investment in research infrastructure by local and overseas organizations as well as engaged stakeholders, Africa should be a research destination for pharma, biotech, government and non-governmental organizations alike.

Continue ReadingHigh-Quality Data and Growing Capacity Make Sub-Saharan Africa a Research Destination

Increasing Clinical Research In Africa Presents An Opportunity To Address Global Health Challenges

Although the diversity of Africa is often cited, the full extent is still not well understood. As we learn more, the true potential of the continent for clinical research to address ongoing public health issues becomes apparent.

Continue ReadingIncreasing Clinical Research In Africa Presents An Opportunity To Address Global Health Challenges

Q&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

In our recent webinar, our panel of esteemed speakers broke stereotypes about Africa, discussed research-related trends and highlighted how clinical trials could benefit from the continent’s strengths.

Continue ReadingQ&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

New Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Several FHI Clinical team members attended the 6th Annual Global Forum on TB Vaccines. Based on their conversations and session attendance, they provide their thoughts on the future of tuberculosis prevention and vaccine development.

Continue ReadingNew Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Personal Choice in Research: Respecting Reasons for Participation and Nonparticipation

As researchers, we rely on the willingness of people to participate in our studies, and participant recruitment and retention continue to be one of the biggest challenges. There are numerous reasons for this, some that we can address and others that we might just have to accept.

Continue ReadingPersonal Choice in Research: Respecting Reasons for Participation and Nonparticipation